FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial
The FDA's decision comes after clinical trial results indicated that lecanemab slows cognitive decline somewhat in people with mild impairment
Read more
Biogen Inc
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
These are the stocks posting the largest moves in midday trading. Source link
Read more
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Names on the move ahead of the open. Source link
Read more
Jim Cramer’s top 10 things to watch in the market Wednesday: Fed’s Powell, data on Alzheimer’s drug, tech earnings
It's the last day of November, and the Dow and S&P 500 are poised to log their second straight month
Read more
Stocks making the biggest moves in the premarket: Hasbro, Oatly, Advanced Micro Devices and more
Names on the move ahead of the open. Source link
Read more
We’re increasing price targets on 3 of our stocks, including 2 crushing the boarder market
Following our price target changes on eight Club holdings last month, we're updating three more Tuesday. Source link
Read more
Earnings could be an even bigger catalyst for stocks after the market’s wild ride on rate fears
Investors are likely to switch their focus to earnings season, after the market's wild ride on rising and falling expectations
Read more
Biogen CEO to step down as the drugmaker plans further Aduhelm cost cuts
Biogen's Chief Executive Officer Michel Vounatsos is stepping down as it is grappling with Medicare restricting coverage for its Alzheimer's
Read more
Here are Monday’s biggest analyst calls of the day: Biogen, Wendy’s, Sirius XM, Amazon & more
Here are the biggest calls on Wall Street on Source link
Read more